Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Sprague, Stuart M, Marcuccilli, Morgan, Rakov, ViatcheslavVolume:
5
Language:
english
Journal:
Clinical Investigation
DOI:
10.4155/cli.14.110
Date:
January, 2015
File:
PDF, 1.10 MB
english, 2015